GRANGEMOUNT BIOSERVICES LTD

Company Registration Number:
NI715589 (Northern Ireland)

Unaudited abridged accounts for the year ended 31 May 2026

Period of accounts

Start date: 01 June 2025

End date: 31 May 2026

GRANGEMOUNT BIOSERVICES LTD

Contents of the Financial Statements

for the Period Ended 31 May 2026

Balance sheet
Notes

GRANGEMOUNT BIOSERVICES LTD

Balance sheet

As at 31 May 2026


Notes
2026
13 months to 31 May 2025


£
£
Fixed assets
Tangible assets: 3 84 112
Total fixed assets: 84 112
Current assets
Debtors:   4,980 22,301
Cash at bank and in hand: 40,895 30,090
Total current assets: 45,875 52,391
Creditors: amounts falling due within one year:   (22,094) (42,450)
Net current assets (liabilities): 23,781 9,941
Total assets less current liabilities: 23,865 10,053
Total net assets (liabilities): 23,865 10,053
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 23,765 9,953
Shareholders funds: 23,865 10,053

The notes form part of these financial statements

GRANGEMOUNT BIOSERVICES LTD

Balance sheet statements

For the year ending 31 May 2026 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 01 September 2026
and signed on behalf of the board by:

Name: Ian Mussen
Status: Director

The notes form part of these financial statements

GRANGEMOUNT BIOSERVICES LTD

Notes to the Financial Statements

for the Period Ended 31 May 2026

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

Turnover policy

Turnover comprises the invoice value of goods supplied by the company, exclusive of trade discounts and value added tax.

Tangible fixed assets and depreciation policy

Property, plant and equipment are stated at cost or at valuation, less accumulated depreciation. Cost comprises purchase price and other directly attributable costs. The charge to depreciation is calculated to write off the original cost or valuation of property, plant and equipment, less their estimated residual value, over their expected useful lives as follows: Fixtures, fittings & equipment 20% Straight Line The carrying values of tangible fixed assets are reviewed annually for impairment in periods if events or changes in circumstances indicate the carrying value may not be recoverable.

GRANGEMOUNT BIOSERVICES LTD

Notes to the Financial Statements

for the Period Ended 31 May 2026

2. Employees

2026 13 months to 31 May 2025
Average number of employees during the period 3 0

GRANGEMOUNT BIOSERVICES LTD

Notes to the Financial Statements

for the Period Ended 31 May 2026

3. Tangible Assets

Total
Cost £
At 01 June 2025 140
At 31 May 2026 140
Depreciation
At 01 June 2025 28
Charge for year 28
At 31 May 2026 56
Net book value
At 31 May 2026 84
At 31 May 2025 112